Novelix Pharma.

{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "82.00",
    "chg": 0.1,
    "chgp": "0.12%",
    "dir": 1,
    "prev_price": "81.90",
    "mcapval": "233.45 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "sector_id": 72,
    "indexname": "India SENSEX",
    "isin": "INE314I01036",
    "curr_date": "Aug 31, 02:27 PM",
    "curr_time": "14:29 PM",
    "last_traded_at": "Aug 31, 02:27 PM IST",
    "bse_nse_vol": "12.41 k",
    "exc_status": "Active",
    "traded_date": "Aug 31, 2026",
    "traded_date_str": "2026 08 31",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-buy-4175835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4175835.png",
        "date": "2026-08-31 10:10:57",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-changing-market-sentiment-4166338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_valuationdot_4166338.png",
        "date": "2026-08-24 08:00:09",
        "description": "Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. This change reflects evolving market perceptions amid robust stock performance and a mixed financial profile, prompting investors to reassess its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Novelix Pharmaceuticals Gains 1.87%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-gains-187-2-key-factors-driving-the-week-4166157",
        "imagepath": "",
        "date": "2026-08-23 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Stock opens at Rs.73.31, down 4.67% amid broader market weakness</p>\n                    <p><strong>18 Aug:</strong> Valuation re-rating announced, signalling renewed price attractiveness</p>\n                    <p><strong>19 Aug:</strong> Downgrade to Hold rating issued amid mixed financial and technical signals</p>\n                    <p><strong>21 Aug:</strong> Week closes at Rs.78.34, up 1.87% for the week, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.73.31</div></div>\n                    <div class=\"stat-item..."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-downgraded-to-hold-amid-mixed-financial-and-technical-signals-4160552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4160552.png",
        "date": "2026-08-19 08:13:06",
        "description": "Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its investment rating downgraded from Buy to Hold as of 18 Aug 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have prompted a more cautious stance."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-buy-4159404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4159404.png",
        "date": "2026-08-18 10:10:57",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4158431",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_valuationdot_4158431.png",
        "date": "2026-08-18 08:00:17",
        "description": "Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling improved price attractiveness for investors within the retailing sector. This change, coupled with robust returns relative to the Sensex, positions the micro-cap stock as a compelling opportunity amid evolving market conditions."
      },
      {
        "title": "When is the next results date for Novelix Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-novelix-pharmaceuticals-ltd-4148857",
        "imagepath": "",
        "date": "2026-08-11 23:18:54",
        "description": "The next results date for Novelix Pharmaceuticals Ltd is scheduled for 13 August 2026...."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4141713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4141713.png",
        "date": "2026-08-07 10:10:03",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 13 February 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4122513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NovelixPharmace_mojoScore_4122513.png",
        "date": "2026-07-27 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 148,
    "sid": "200695",
    "stock_news_url": "https://www.marketsmojo.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 29Th August 2026",
      "datetime": "29-Aug-2026",
      "details": "Submission of outcome of the board meeting.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday 29Th August 2026",
      "datetime": "25-Aug-2026",
      "details": "Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 inter alia to consider and approve Submission of Prior intimation of Board Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Lease Deed",
      "datetime": "20-Aug-2026",
      "details": "Submission of Intimation of Land Lease Deed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Novelix Pharmaceuticals Ltd is Rated Buy

2026-08-31 10:10:57

Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd Valuation Shifts Signal Changing Market Sentiment

2026-08-24 08:00:09

Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. This change reflects evolving market perceptions amid robust stock performance and a mixed financial profile, prompting investors to reassess its price attractiveness relative to peers and historical benchmarks.

Read full news article

Novelix Pharmaceuticals Gains 1.87%: 2 Key Factors Driving the Week

2026-08-23 14:00:06

Key Events This Week

17 Aug: Stock opens at Rs.73.31, down 4.67% amid broader market weakness

18 Aug: Valuation re-rating announced, signalling renewed price attractiveness

19 Aug: Downgrade to Hold rating issued amid mixed financial and technical signals

21 Aug: Week closes at Rs.78.34, up 1.87% for the week, outperforming Sensex

Week Open

Rs.73.31

Read full news article

Novelix Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals

2026-08-19 08:13:06

Novelix Pharmaceuticals Ltd, a micro-cap player in the retailing sector, has seen its investment rating downgraded from Buy to Hold as of 18 Aug 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have prompted a more cautious stance.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Buy

2026-08-18 10:10:57

Novelix Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-18 08:00:17

Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling improved price attractiveness for investors within the retailing sector. This change, coupled with robust returns relative to the Sensex, positions the micro-cap stock as a compelling opportunity amid evolving market conditions.

Read full news article

When is the next results date for Novelix Pharmaceuticals Ltd?

2026-08-11 23:18:54

The next results date for Novelix Pharmaceuticals Ltd is scheduled for 13 August 2026....

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-08-07 10:10:03

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 13 February 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-07-27 10:10:04

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

View All News